跳至主要内容
临床试验/NCT06410443
NCT06410443招募中不适用

Efficacy and Safety of Local Glucocorticoids for the Treatment of Acute Radiation-Induced Intestinal Injury: A Randomized Controlled Trial

General Hospital of Shenyang Military Region1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年8月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
60
试验地点
1
主要终点
Recovery and/or improvement

研究概览

简要总结

Due to the increasing number and prolonged survival of malignant tumor patients treated with radiotherapy, the complication, such as acute radiation-induced intestinal injury, has become increasingly significant. Glucocorticoids may play a therapeutic role by regulating the inflammatory response in patients with acute radiation-induced intestinal injury. However, the conclusions of related studies were controversial.

详细描述

A total of 60 patients with acute radiation-induced intestinal injury will be enrolled. They will be randomly assigned at a 1:1 ratio into glucocorticoid group and standard treatment group. The primary endpoint is the recovery and improvement of acute radiation-induced intestinal injury. The secondary study endpoints include the recurrence and aggravation of radiation-induced intestinal injury, and adverse events.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Grade II-III acute radiation-induced rectosigmoid injury
  • Signed informed consents
  • Age ≥18 years
  • Rstimated survival time >1 year

排除标准

  • Absolute contraindications to glucocorticoids
  • A history of glucocorticoids treatment within 3 months
  • Inflammatory bowel disease or infectious intestinal disease
  • Recurrence of malignant tumor
  • Colorectal cancer or metastasis
  • Severe heart or lung diseases
  • Recent history of surgery or trauma
  • Poorly controlled hyperglycemia and hypertension
  • Active tuberculosis
  • Ssevere gastrointestinal ulcers
  • Sychiatric diseases
  • Pregnant or lactating

研究组 & 干预措施

Glucocorticoids+routine treatment group

Experimental

Dexamethasone retention enema

干预措施: Dexamethasone (Drug)

Glucocorticoids+routine treatment group

Experimental

Dexamethasone retention enema

干预措施: Antibiotics, probiotics, vitamins, antidiarrheal drugs, enteral nutrition, and endoscopic argon plasma coagulation (Drug)

Routine treatment group

Active Comparator

Routine treatment of acute radiation-induced intestinal injury according to the current practice guideline

干预措施: Antibiotics, probiotics, vitamins, antidiarrheal drugs, enteral nutrition, and endoscopic argon plasma coagulation (Drug)

结局指标

主要结局

Recovery and/or improvement

时间窗: 3 months

1. If patients' clinical symptoms, including abdominal pain, diarrhea, and hematochezia, and intestinal mucosal lesions under endoscopy disappear, the recovery will be defined. 2. If patients' clinical symptoms alleviate, and/or the Vienna scores evaluated by endoscopy decrease at least 1 point, the improvement will be defined. The total number and frequency of patients who have both recovery and improvement of radiation-induced intestinal injury after treatment is calculated as the treatment efficacy.

次要结局

  • Recurrence and/or aggravation(1 year)
  • Adverse events(1 year)

研究者

发起方
General Hospital of Shenyang Military Region
申办方类型
Other
责任方
Principal Investigator
主要研究者

Xingshun Qi

Director of Department of Gastroenterology

General Hospital of Shenyang Military Region

研究点 (1)

Loading locations...

相似试验